The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema

Background/Aims. To assess the effect of intravitreal bevacizumab injection (IVBI) for the treatment of macular edema due to infectious and noninfectious uveitides. Design. Retrospective interventional case series. Methods. A chart review was performed on all the patients who were diagnosed with uve...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hassan Al-Dhibi, Issam H. Hamade, Ali Al-Halafi, Maan Barry, Charbel Bou Chacra, Vishali Gupta, Khalid F. Tabbara
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2014/729465
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Jia-Kang Wang, et al.
Published: (2016-01-01)

The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation
by: Ristić Dragana, et al.
Published: (2013-01-01)

Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Takafumi Hirashima, et al.
Published: (2014-01-01)

Risk factors and Response of Branch Retinal Vein Occlusion induced Macular Edema to intravitreal injections of Triamcinolone and Bevacizumab
by: Singhai Prakhar, et al.
Published: (2017-07-01)

Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry
by: Jurgen Sota, et al.
Published: (2025-07-01)

Full Thickness Macular Hole Following Intravitreal Bevacizumab for A Vascularised Pigment Epithelial Detachment
by: Neha Goel
Published: (2021-04-01)

Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
by: Cassandra C. Lautredou, et al.
Published: (2018-01-01)

Short-term real-world outcomes of diabetic macular edema treated with intravitreal faricimab.
by: Toshiaki Hirakata, et al.
Published: (2025-01-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01)

Phacoemulsification surgery in patients with diabetic macular edema: should intravitreal anti-VEGF therapy be performed before or simultaneously with surgery?
by: Yusuf Ziya Güven, et al.
Published: (2025-04-01)

One-year results of visual response following intravitreal novel anti-VEGF injection for diabetic macular edema in a Latino population
by: Guillermo Salcedo-Villanueva, et al.
Published: (2025-08-01)

Real-world clinical insights and aqueous humor biomarker analysis of diabetic macular edema subtypes classified by OCT following intravitreal injections
by: Liangzhang Tan, et al.
Published: (2025-07-01)

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity
by: Rebecca Kim, et al.
Published: (2014-01-01)

Corticosteroid Treatment in Diabetic Macular Edema
by: Burcu Nurözler Tabakcı, et al.
Published: (2017-06-01)

Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
by: John R. Gonder, et al.
Published: (2014-01-01)

Modern aproaches to diabetic macular edema diagnosticks
by: A. V. Doga, et al.
Published: (2020-08-01)

The impact of switching from anti-VEGF therapy to dexamethasone intravitreal implant on refractory macular edema in patients with retinal vein occlusion: A systematic review and meta-analysis
by: He-Ping Zhang, et al.
Published: (2025-08-01)

Efficacy and safety of fluocinolone acetonide intravitreal implant (0.2 µg/day) in patients with post-surgical inflammation associated with macular edema: a case series study
by: Maria Madeira, et al.
Published: (2025-08-01)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
by: Tranos P, et al.
Published: (2024-11-01)

Retinopathy of Prematurity (ROP)—Risk Factors and Therapeutic Effect of Intravitreal Injection of Bevacizumab (IVB): An Observational Study from a Neonatal Intensive Care Unit in Egypt
by: Ehab Mohamed Hantash, et al.
Published: (2024-04-01)

Modern diagnostic and treatment aspects of diabetic macular edema
by: Alexander Viktorovich Doga, et al.
Published: (2014-12-01)

Short and long-term impact of intravitreal anti-VEGF therapy interruption in retinal vein occlusion during the COVID-19 pandemic: functional outcomes and AI-based fluid analysis of macular edema
by: Emmanuelle Moret, et al.
Published: (2025-08-01)

The Analysis of Risk Factors of Development of Macular Edema after Phacoemulsification
by: V. L. Kokorev
Published: (2019-06-01)

The Ellipsoid Zone Is a Structural Biomarker for Visual Outcomes in Diabetic Macular Edema and Macular Hole Management
by: Shivani Chaturvedi, et al.
Published: (2025-01-01)

Changes in retinal vascular geometry after vitrectomy in idiopathic and uveitic epiretinal membrane
by: Chang Hwan Lee, et al.
Published: (2025-07-01)

Intraretinal macrocysts fully filled with hyperreflective material in diabetic macular edema
by: Denizcan Özizmirliler, et al.
Published: (2025-07-01)

Cataract surgery and the risk of developing recurrence or progression of diabetic macular edema.
by: Mirinae Kim, et al.
Published: (2025-01-01)

THE ROLE OF VASCULAR GROWTH FACTORS IN DIABETIC RETINOPATHY AND MACULAR EDEMA DEVELOPMENT
by: A. G. Iskhakova, et al.
Published: (2018-10-01)

Development of Clinical and Morphometric Classification of Macular Edema in Retinal Vein Occlusions
by: A. A. Fil, et al.
Published: (2022-07-01)

Two cases of lamellar macular hole secondary to the rupture of the cystoid inner wall in patients with diabetic macular edema
by: Zhi-Hui Dong, et al.
Published: (2025-08-01)

Real-World 5-Year Outcomes of Age-Related Macular Degeneration with Bevacizumab as First-Line Anti-VEGF
by: H. Mhmud, et al.
Published: (2025-06-01)

Impact of epiretinal membrane peeling on steroid dependency in uveitic eyes: a retrospective analysis
by: Verena Schöneberger, et al.
Published: (2025-07-01)

Exploring the role of hyperreflective walls as a biomarker for the management of cystoid macular edema
by: Zhang-Rong Yang, et al.
Published: (2025-09-01)

Systemic Associations with Residual Subretinal Fluid after Ranibizumab in Diabetic Macular Edema
by: Meng-Ju Tsai, et al.
Published: (2017-01-01)

Real-World Treatment Patterns and Vision Outcomes with Ranibizumab for Diabetic Macular Edema
by: Tadas Naujokaitis, et al.
Published: (2021-01-01)

Suprachoroidal implantation of corticosteroid slow release implants for the treatment of cystoid macular edema
by: Ben Asani, et al.
Published: (2025-06-01)

FEATURES OF REHABILITATION OF THE PATIENTS AFTER NONINFECTIOUS COMPLICATIONS OF TOTAL HIP ARTHROPLASTY
by: V. A. Neverov, et al.
Published: (2016-04-01)

Quantitative characterization of types 1 and 2 macular neovascularization in neovascular age-related macular degeneration with intravitreal conbercept: an analysis utilizing optical coherence tomography angiography
by: Yan-Mei Shi, et al.
Published: (2025-08-01)

Faricimab in the Treatment of Exudative Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Italy: The FARIT Real World Study
by: Marco Lupidi, et al.
Published: (2025-07-01)